Abiopharma

Clinical trial NCT07271251 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-08-03 → 2026-08-04 3. enrollment: 264 → 267 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07484230 updates: 1. status: NOT_YET_RECRUITING → WITHDRAWN 2. enrollment: 20 → 0 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07552558 updates: 1. start date: 2026-06-30 → 2026-09-30 2. completion date: 2033-08-31 → 2033-11-30 3. primary completion date: 2028-08-31 → 2028-11-30

Clinical trial NCT07593092 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-06-30

Clinical trial NCT03409432: collaborators added: Celgene Corporation.

Clinical trial NCT07265258 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-12-30 → 2026-07-30 3. completion date: 2027-09-04 → 2028-12-30 4. primary completion date: 2026-09-12 → 2028-06-30

Odysight.ai Reports Financial Results for the First Half of 2026 and Provides Business Update

Kimberly-Clark Appoints Suzana Blades as Senior Vice President and General Counsel

SuperCom Reports Record Revenue and Record EBITDA of $4 Million in the Second Quarter of 2026

Odysight.ai signs agreement with Boeing to demonstrate AI-Powered capabilities